R&D Progress: Enrollment of Subjects in Phase III Clinical Trial for Inhaled Aerosol Drug in Children by Kexing Biopharm
Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk
View original content:https://www.prnewswire.co.uk/news-releases/rd-progress-enrollment-of-subjects-in-phase-iii-clinical-trial-for-inhaled-aerosol-drug-in-children-by-kexing-biopharm-302112540.html
en | boerse | 67939964 |
